SE420566B - DIAGNOSTIZER FOR INTRAVASCULAR ADMINISTRATION - Google Patents
DIAGNOSTIZER FOR INTRAVASCULAR ADMINISTRATIONInfo
- Publication number
- SE420566B SE420566B SE7407461A SE7407461A SE420566B SE 420566 B SE420566 B SE 420566B SE 7407461 A SE7407461 A SE 7407461A SE 7407461 A SE7407461 A SE 7407461A SE 420566 B SE420566 B SE 420566B
- Authority
- SE
- Sweden
- Prior art keywords
- june
- blood plasma
- water
- intravascularly
- intravascular administration
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
- A61K51/1217—Dispersions, suspensions, colloids, emulsions, e.g. perfluorinated emulsion, sols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/0004—Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
- A61K51/1241—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules particles, powders, lyophilizates, adsorbates, e.g. polymers or resins for adsorption or ion-exchange resins
- A61K51/1244—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules particles, powders, lyophilizates, adsorbates, e.g. polymers or resins for adsorption or ion-exchange resins microparticles or nanoparticles, e.g. polymeric nanoparticles
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B31/00—Preparation of derivatives of starch
- C08B31/003—Crosslinking of starch
- C08B31/006—Crosslinking of derivatives of starch
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2123/00—Preparations for testing in vivo
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Optics & Photonics (AREA)
- Pharmacology & Pharmacy (AREA)
- Physics & Mathematics (AREA)
- Dispersion Chemistry (AREA)
- Materials Engineering (AREA)
- Gastroenterology & Hepatology (AREA)
- Nanotechnology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Polymers & Plastics (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Biochemistry (AREA)
- Pathology (AREA)
- Rheumatology (AREA)
- Toxicology (AREA)
- Urology & Nephrology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
1518813 Diagnostic agents PHARMACIA AB 5 June 1975 [6 June 1974] 24287/75 Heading A5B [Also in Divisions C3 and G1] A diagnostic agent for intravascular administration and subsequent analysis in vivo or in vitro consists of a radioactive component, e.g. Tc<SP>99m</SP> (e.g. sodium pertechnetate) which is bound to, and/or enclosed in and/or exists in admixture with particles of a water-insoluble but hydrophilic, swellable, three dimensional network of molecules of a polyglucose polymer or physiologically acceptable derivative thereof which is cross linked covalently, the network being degradable by 2-amylase in blood plasma into water-soluble fragments either directly or subsequent to a preliminary splitting-off of substituents which may be present in the polysaccharide through the action of an enzyme in blood plasma (see Division C3). The compositions may be administered intravascularly whereafter the radioactive radiation is measured over the relevant body portion or on a sample taken from the body (e.g. an intravascularly taken sample).
Priority Applications (8)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE7407461A SE420566B (en) | 1974-06-06 | 1974-06-06 | DIAGNOSTIZER FOR INTRAVASCULAR ADMINISTRATION |
AU81646/75A AU8164675A (en) | 1974-06-06 | 1975-05-29 | A diagnostic agent |
DE19752524278 DE2524278A1 (en) | 1974-06-06 | 1975-05-31 | DIAGNOSTIC MEANS, AIDS FOR PRODUCTION AND DIAGNOSIS METHODS |
CA228,779A CA1039274A (en) | 1974-06-06 | 1975-06-05 | Diagnostic agent |
GB24287/75A GB1518813A (en) | 1974-06-06 | 1975-06-05 | Diagnostic agent |
FR7517632A FR2273516A1 (en) | 1974-06-06 | 1975-06-05 | DIAGNOSIS AGENT FOR INTRAVASCULAR ADMINISTRATION |
NL7506743A NL7506743A (en) | 1974-06-06 | 1975-06-06 | DIAGNOSTIC. |
JP50067731A JPS517113A (en) | 1974-06-06 | 1975-06-06 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE7407461A SE420566B (en) | 1974-06-06 | 1974-06-06 | DIAGNOSTIZER FOR INTRAVASCULAR ADMINISTRATION |
Publications (2)
Publication Number | Publication Date |
---|---|
SE7407461L SE7407461L (en) | 1975-12-08 |
SE420566B true SE420566B (en) | 1981-10-19 |
Family
ID=20321348
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE7407461A SE420566B (en) | 1974-06-06 | 1974-06-06 | DIAGNOSTIZER FOR INTRAVASCULAR ADMINISTRATION |
Country Status (8)
Country | Link |
---|---|
JP (1) | JPS517113A (en) |
AU (1) | AU8164675A (en) |
CA (1) | CA1039274A (en) |
DE (1) | DE2524278A1 (en) |
FR (1) | FR2273516A1 (en) |
GB (1) | GB1518813A (en) |
NL (1) | NL7506743A (en) |
SE (1) | SE420566B (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1985002772A1 (en) * | 1983-12-21 | 1985-07-04 | Schroeder Ulf | Diagnostic and contrast agent |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0093757A1 (en) * | 1981-11-12 | 1983-11-16 | Ulf SCHRÖDER | Intravascularly administrable, magnetically responsive nanosphere or nanoparticle, a process for the production thereof, and the use thereof |
FR2548902B1 (en) * | 1983-07-13 | 1986-04-11 | Guerbet Sa | THERAPEUTIC EMBOLIZATION GEL |
-
1974
- 1974-06-06 SE SE7407461A patent/SE420566B/en unknown
-
1975
- 1975-05-29 AU AU81646/75A patent/AU8164675A/en not_active Expired
- 1975-05-31 DE DE19752524278 patent/DE2524278A1/en not_active Withdrawn
- 1975-06-05 CA CA228,779A patent/CA1039274A/en not_active Expired
- 1975-06-05 FR FR7517632A patent/FR2273516A1/en active Granted
- 1975-06-05 GB GB24287/75A patent/GB1518813A/en not_active Expired
- 1975-06-06 NL NL7506743A patent/NL7506743A/en not_active Application Discontinuation
- 1975-06-06 JP JP50067731A patent/JPS517113A/ja active Pending
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1985002772A1 (en) * | 1983-12-21 | 1985-07-04 | Schroeder Ulf | Diagnostic and contrast agent |
Also Published As
Publication number | Publication date |
---|---|
DE2524278A1 (en) | 1975-12-18 |
CA1039274A (en) | 1978-09-26 |
SE7407461L (en) | 1975-12-08 |
FR2273516A1 (en) | 1976-01-02 |
FR2273516B1 (en) | 1979-01-05 |
GB1518813A (en) | 1978-07-26 |
AU8164675A (en) | 1976-12-02 |
JPS517113A (en) | 1976-01-21 |
NL7506743A (en) | 1975-12-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0787017B2 (en) | Diagnostic preparation for detection of helicobacter pylori | |
CA1165686A (en) | Radioactive diagnostic agent and non-radioactive carrier therefor | |
JPS60155138A (en) | Manufacture of heparin or heparinoid with improved intestinal absorption and medicine thereof | |
US4071613A (en) | Stabilized alcohol solution of reducing salt formulations for use in preparing radioisotope labeled scanning agents: liver scanning technetium-99m colloid and method of preparation | |
NL7506743A (en) | DIAGNOSTIC. | |
Whitby | Enzymic formation of a new riboflavin derivative | |
Schilsky et al. | Biliary copper excretion capacity in intact animals: correlation between ATP7B function, hepatic mass, and biliary copper excretion | |
Ekenved | ABSORPTION FROM DIFFERENT TYPES OF IRON TABLETS‐CORRELATION BETWEEN SERUM IRON INCREASE AND TOTAL ABSORPTION OF IRON | |
EP0063946A1 (en) | Diagnosis of kidney function | |
DE69001000T2 (en) | RADIOACTIVE DIAGNOSTIC. | |
Esquerre et al. | Kinetics of technetium-labeled heparin in thromboembolism: Preliminary Report | |
Ainsworth | An ultrastructural method for the use of polyvinylpyrrolidone and dextrans as electron opaque tracers. | |
EP0280135A2 (en) | Protein C-inhibitor (PCI) as a pharmaceutical and diagnostic agent, process for the preparation of such a pharmaceutical or diagnostic agent and a composition containing PCI | |
Caputo et al. | Letterer-Siwe disease in an octogenarian | |
Balaban et al. | Effect of the radiolabel mediator tropolone on lymphocyte structure and function | |
Hudson et al. | Tumour uptake of thallium-201 chloride | |
Turan et al. | Evaluation of 99m Tc-citrate, 67 Gacitrate and 99m Tc (V) dimercaptosuccinic acid for the scintigraphic visualization of acute appendicitis | |
Rosenau | Dangers in the use of certain halogenated phthaleins as functional tests | |
JPS5842846B2 (en) | Technetium-99m labeled radiological diagnostic agent for liver and bone marrow scanning and its manufacturing method | |
JPS63170400A (en) | Radioactive medicine and high polymer compound for preparation thereof | |
GB2055044A (en) | Glucuronidase activity and/or phdependent pharmaceuticals and their methods of production and use for selective treatment of diseases | |
Duchon | Tyrosine metabolism in melanoma | |
JPS60126231A (en) | Radioactie diagnostic agent | |
Perin et al. | Evaluation of possible interference of anti-inflammatory drugs upon scintigraphic imaging with macrophage targeting 99mTc-J001X: Effects of methylprednisolone, dexamethasone, indomethacin and methotrexate | |
Chatterjee Debnath et al. | Technetium-99m cysteine; a novel radiopharmaceutical for detection of experimental myocardial infarction in rats |